Thyrocare Technologies Limited — Financials & Forensics
Sector: Healthcare · NSE: THYROCARE · BSE: 539871 · ISIN: INE594H01019
18 Aug 2026
Add THYROCARE to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹589 Cr | ₹527 Cr | ₹572 Cr | ₹687 Cr | ₹829 Cr |
| EBITDA | ₹235 Cr | ₹120 Cr | ₹137 Cr | ₹190 Cr | ₹262 Cr |
| EBITDA margin | 39.9% | 22.8% | 24.0% | 27.7% | 31.6% |
| Profit after tax | ₹176 Cr | ₹64 Cr | ₹71 Cr | ₹92 Cr | ₹163 Cr |
Deeper analysis
Recent filings by Thyrocare Technologies Limited
-
Updates
24 Jul 2026 · Financial Results
-
Please find attached herewith Newspaper Publication of Unaudited Financial Results for the quarter e
24 Jul 2026 · Financial Results
-
Audio Recording of Earnings Conference Call for the quarter ended on June 30, 2026
23 Jul 2026 · General Update
-
Please refer the enclosed intimation regarding the in-principle approval of the Board of Directors o
23 Jul 2026 · Corporate Action
-
Please find attached the Investor Presentation on the Unaudited Financial Results (Standalone and Co
23 Jul 2026 · Financial Results
Never miss a filing again
About Thyrocare Technologies Limited on Indian Stock Alerts
Indian Stock Alerts tracks Thyrocare Technologies Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.